NAHC’s HAA Seeks Delay of Hospice Prescription Drug Reporting --MACs post updated FAQ on CR 8358
March 18, 2014 10:32 AM
Alert: NAHC’s HAA is sponsoring a webinar on CR8358: ADDITIONAL DATA ON CLAIMS on Tuesday, March 18 from 1 to 2:30 p.m. EASTERN for the low price of $125 per site, member or non-member.
For additional information please go to:
3/18/14 Online registration form
3/18/14 Product registration form
In a letter dated March 7, 2014, the National Association for Home Care & Hospice’s (NAHC) affiliated Hospice Association of America (HAA) urged representatives of the Centers for Medicare & Medicaid Services (CMS) to postpone the April 1 deadline for mandatory reporting of prescription drugs on hospice claims as required by Change Request (CR) 8358, citing “continuing concerns about the hospice industry’s ability to provide timely and accurate information on claims for prescription drugs.”
Additional time is sought to allow for a more orderly transition resulting in more accurate data on the claim. The letter references discussion on a recent CMS Open Door Forum at which a hospice representative described the particular challenges hospices are experiencing in securing prescription drug data from hospitals with which the hospices contract for general inpatient care. Some hospitals are seeking to renegotiate contracts with their hospice partners as a condition of supplying the additional information.
HAA indicates that the process for meeting the prescription drug reporting requirements has been complex, and has included coordination with software vendors and pharmacy partners, securing clarification from CMS and its Medicare Administrative Contractors (MACs), development of software solutions, staff training, development of charge structures, and (in many cases) establishment of internal processes by which the hospice would manually look up and enter the required National Drug Code (NDC) and/or HCPCS for each drug.
“Developing the solutions to ensure compliance and accuracy in reporting have been labor intensive and time consuming, and these solutions have had to be addressed in sequence.” HAA also cites concerns about cash flow issues in cases where hospices are not able to secure the required drug information on a timely basis and as a result must delay claims submission or, in the alternative, submit incomplete claims and a subsequent adjusted claim at a later date.
In related news, CMS’ Medicare Administrative Contractors (MACs) have coordinated to post a single, consolidated list of FAQs related to CR8358 on Friday, March 14. The link provided will take you to the Palmetto GBA posting of the list. Additionally, NAHC will be posting the link to the consolidated FAQs on its website in the immediate future.